ATE96678T1 - Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen. - Google Patents

Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.

Info

Publication number
ATE96678T1
ATE96678T1 AT89114676T AT89114676T ATE96678T1 AT E96678 T1 ATE96678 T1 AT E96678T1 AT 89114676 T AT89114676 T AT 89114676T AT 89114676 T AT89114676 T AT 89114676T AT E96678 T1 ATE96678 T1 AT E96678T1
Authority
AT
Austria
Prior art keywords
performance
skin irritation
medicinal compositions
composition
reducing skin
Prior art date
Application number
AT89114676T
Other languages
English (en)
Inventor
Dinesh C Patel
Charles D Ebert
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22907535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE96678(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of ATE96678T1 publication Critical patent/ATE96678T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
AT89114676T 1988-09-06 1989-08-08 Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen. ATE96678T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/240,688 US4855294A (en) 1988-09-06 1988-09-06 Method for reducing skin irritation associated with drug/penetration enhancer compositions
EP89114676A EP0416137B1 (de) 1988-09-06 1989-08-08 Verfahren zur Verminderung von Hautirritationen bei Anwendung von durchdringungsverstärkenden Arzneimittelzusammensetzungen

Publications (1)

Publication Number Publication Date
ATE96678T1 true ATE96678T1 (de) 1993-11-15

Family

ID=22907535

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89114676T ATE96678T1 (de) 1988-09-06 1989-08-08 Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.

Country Status (8)

Country Link
US (1) US4855294A (de)
EP (1) EP0416137B1 (de)
JP (1) JP2953625B2 (de)
KR (1) KR0143916B1 (de)
AT (1) ATE96678T1 (de)
CA (1) CA1332570C (de)
DE (1) DE68910520T2 (de)
ES (1) ES2053882T3 (de)

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE104554T1 (de) * 1990-01-10 1994-05-15 Hoffmann La Roche Topische praeparate.
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5276079A (en) * 1991-11-15 1994-01-04 Minnesota Mining And Manufacturing Company Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same
US6284754B1 (en) * 1992-01-20 2001-09-04 Schwarz Pharma Ag Pharmaceutical compositions containing 1-oleylazacycloheptan-2-one as enhancing agent of transport across biological membranes
ATE184473T1 (de) * 1992-06-11 1999-10-15 Theratech Inc Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
CN1076972C (zh) * 1992-07-23 2002-01-02 久光制药株式会社 经皮肤给药的基剂组合物及其药剂组合物
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
DE19610396C2 (de) * 1996-03-16 1998-11-26 Krewel Meuselbach Gmbh Dimethylsulfoxid-haltige topische Zubereitung
WO1998018416A1 (en) * 1996-10-30 1998-05-07 Theratech, Inc. Fatty acid esters of glycolic acid and its salts as permeation enhancers
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
ZA984649B (en) * 1997-06-13 1999-12-17 Cryopreservation Tech Cc "Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes".
US6319913B1 (en) 1997-11-10 2001-11-20 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems
US6180133B1 (en) * 1997-11-25 2001-01-30 Watson Pharmaceuticals, Inc. Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE69939019D1 (de) * 1998-07-07 2008-08-14 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht-irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US7179475B1 (en) 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US6232366B1 (en) 1999-06-09 2001-05-15 3M Innovative Properties Company Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same
KR100369779B1 (ko) * 1999-07-12 2003-01-29 주식회사 엘지생명과학 교감신경 흥분성 기관지확장 약물의 경피흡수 투여용 조성물및 이를 포함하는 경피흡수 투여용 제형
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
EP1159956B1 (de) * 2000-05-01 2006-09-06 Johnson & Johnson Consumer Companies, Inc. Wasserfreie topische Zubereitungen für die Haut
US20060121103A1 (en) * 2000-05-11 2006-06-08 Kenneth Kirby Transdermal delivery system
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
JP4358978B2 (ja) * 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
KR20030028253A (ko) * 2001-09-27 2003-04-08 (주)지씨아이 잔탄검과 알긴을 이용한 항고지단백혈증 경피투과제제의제조
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US6765001B2 (en) * 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
KR101108439B1 (ko) 2002-10-25 2012-01-31 포믹스 리미티드 화장료 및 약제용 거품제
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US9278155B2 (en) 2003-06-05 2016-03-08 3M Innovative Properties Company Adhesive compositions, articles incorporating same and methods of manufacture
US20040247654A1 (en) * 2003-06-05 2004-12-09 3M Innovative Properties Company Hydrophilic adhesives for delivery of herbal medicines
JP4596751B2 (ja) * 2003-06-11 2010-12-15 帝國製薬株式会社 消炎鎮痛貼付剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
US9757596B2 (en) * 2004-11-29 2017-09-12 Ambria Dermatology Ab Composition comprising at least 3 different diols
AU2005311896A1 (en) * 2004-12-02 2006-06-08 Omp, Inc. System for improved percutaneous absorption of skin benefiting agents
US7999023B2 (en) * 2004-12-03 2011-08-16 3M Innovative Properties Company Process for making pressure sensitive adhesive hydrogels
US10137135B2 (en) * 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US20070179121A1 (en) * 2006-02-02 2007-08-02 Plott R T Method of treating pediatric patients with corticosteroids
US7905852B2 (en) * 2006-05-16 2011-03-15 Barbara Jennings-Spring Skin-contacting-adhesive free dressing
US7645252B2 (en) * 2006-05-16 2010-01-12 Barbara Brooke Jennings-Spring Body or plant part dressing
BRPI0717769A2 (pt) * 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
ES2753850T3 (es) * 2007-01-29 2020-04-14 Nat Res Council Canada Uso de catecolaminas y compuestos relacionados como agentes antiangiogénicos
KR101521989B1 (ko) * 2007-03-02 2015-05-28 테이카 세이야쿠 가부시키가이샤 경피흡수 의약조성물, 의약조성물 저장유닛 및 이것을 이용하는 경피흡수제제
US20100210932A1 (en) * 2007-03-20 2010-08-19 Bayer Healthcare Llc Method of analyzing an analyte
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8927537B2 (en) * 2007-12-21 2015-01-06 Nuvo Research Inc. Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
EP2482788B1 (de) 2009-10-02 2022-12-14 Journey Medical Corporation Topische tetracyclinzusammensetzungen
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
CA2898626C (en) 2013-01-24 2020-05-12 Irhythm Technologies, Inc. Physiological monitoring device
MX2016003922A (es) 2013-09-30 2016-06-17 3M Innovative Properties Co Copolimeros de silicona-polieter, adhesivos y articulos medicos que los comprenden, y metodos para elaborarlos.
CN116530951A (zh) 2014-10-31 2023-08-04 意锐瑟科技公司 无线生理监测装置和系统
WO2017044458A1 (en) * 2015-09-08 2017-03-16 The University Of Toledo Treatment of raynaud's phenomenon by inhibition of transient receptor potential melastatin-8 (trpm-8)
CN113413375A (zh) * 2016-05-30 2021-09-21 傅远桥 皮肤多种损伤创面治疗的外用药物组合物及其制备方法
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US20220154041A1 (en) 2019-04-01 2022-05-19 3M Innovative Properties Company Process for making pressure sensitive adhesive hydrogels
EP3750528A1 (de) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Zusammensetzungen zur behandlung von dystrophien und myotonie
CA3171482C (en) 2020-02-12 2024-03-26 Irhythm Technologies, Inc Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient
US11350864B2 (en) 2020-08-06 2022-06-07 Irhythm Technologies, Inc. Adhesive physiological monitoring device
JP2023536982A (ja) 2020-08-06 2023-08-30 アイリズム・テクノロジーズ・インコーポレイテッド 生理学的モニタリング装置の電気部品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1408384A (en) * 1920-06-21 1922-02-28 Thomas J Newlyn Cosmetic lotion
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
EP0095813A3 (de) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Durchdringende topische pharmazeutische Präparate, die 9-(2-Hydroxyäthoxymethyl)-guanin enthalten
GR77517B (de) * 1982-06-30 1984-09-24 Procter & Gamble
EP0105657B1 (de) * 1982-09-30 1992-05-27 Lancaster Group Ag Glycerinhaltige kosmetische Mittel
US4537776A (en) * 1983-06-21 1985-08-27 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
DE3779999T2 (de) * 1986-11-14 1992-12-10 Theratech Inc Erhoehung des penetrationsvermoegens mittels eines aus die zellhuelle veraendernden substanzen und kurzkettigen alkoholen bestehenden binaeren systems.

Also Published As

Publication number Publication date
DE68910520T2 (de) 1994-04-07
EP0416137B1 (de) 1993-11-03
ES2053882T3 (es) 1994-08-01
KR900004330A (ko) 1990-04-12
EP0416137A1 (de) 1991-03-13
US4855294A (en) 1989-08-08
DE68910520D1 (de) 1993-12-09
JP2953625B2 (ja) 1999-09-27
JPH02115131A (ja) 1990-04-27
CA1332570C (en) 1994-10-18
KR0143916B1 (ko) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE96678T1 (de) Verfahren zur verminderung von hautirritationen bei anwendung von durchdringungsverstaerkenden arzneimittelzusammensetzungen.
DE69401945T2 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE68914185D1 (de) Betäubungs- und Feuchtigkeitszusammensetzung und Verfahren zur Herstellung.
DE68918943D1 (de) Gewebeentzusammensetzung und verfahren.
BR9403783A (pt) Uso de uma composição cosmética
EP0377836A3 (de) Verfahren und Mittel zur Haarpflege
ATA162587A (de) Verfahren zur herstellung von neuen benzolderivaten sowie von diese derivate enthaltenden pharmazeutischen zusammensetzungen und verfahren zur verringerung von entzündung bei tieren
ATE222505T1 (de) Flüssige polymerzusammensetzung und verfahren zu ihrer verwendung
EP0164998A3 (de) Mittel und Verfahren zur Erhöhung der transdermalen und transmembranen Penetration topischer und systemischer Wirkstoffe
MY110734A (en) Improvements in or relating to dioic acids.
EE9900428A (et) Köhavastased ravimkoostised
EP0506658A4 (en) Compositions and method for treating painful, inflammatory or allergic disorders
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE83668T1 (de) Pflaster zur transdermalen anwendung.
MX170055B (es) , "composicion insecticida y procedimiento para su obtencion
ES2059756T3 (es) Composiciones farmaceuticas que contienen primicina.
DE69131058T2 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
KR920702623A (ko) 진해제
ATE318612T1 (de) Methoden und zusammensetzungen zur behandlung der hyperlipidämie
ATE103279T1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
ATE103764T1 (de) Verfahren zur bekaempfung von fichtenborkenkaefern und zusammensetzung dafuer.
AT364078B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit verlaengerter broncholytischer und tokolytischer wirksamkeit
MX9707868A (es) La triacetina como incrementador de penetracion transdermica.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee